OSCR Stock Recent News
OSCR LATEST HEADLINES
Oscar Health, Inc. (NYSE:OSCR ) Q2 2024 Earnings Conference Call August 7, 2024 8:00 AM ET Company Participants Chris Potochar - VP, Treasury and IR Mark Bertolini - CEO Scott Blackley - CFO Conference Call Participants Steve Baxter - Wells Fargo Jessica Tassan - Piper Sandler Joshua Raskin - Nephron Research Adam Ron - Bank of America Olivia Miles - Baird Operator Good morning, everyone. My name is Ellie, and I will be your conference operator for today.
Oscar Health, Inc. (OSCR) came out with quarterly earnings of $0.20 per share, beating the Zacks Consensus Estimate of $0.16 per share. This compares to loss of $0.07 per share a year ago.
Oscar Health Wednesday reported $56 million in net income – its second quarterly profit in the company's 12-year history – as the provider of individual coverage under the Affordable Care Act grows its health plans for consumers and employers.
NEW YORK--(BUSINESS WIRE)--Oscar Health Announces Results for Second Quarter 2024 and Raises Full Year Revenue and Adjusted EBITDA Outlook.
Oscar Health's (OSCR) Q2 results are likely to reflect membership growth, prudent pricing and improved cost-of-care initiatives.
Analysts have noticed that Harris's 2024 campaign for president is a bit different than what it was in 2024, as quoted on yahoo finance.
Oscar Health (OSCR) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Here is how Oscar Health, Inc. (OSCR) and Acadia Realty Trust (AKR) have performed compared to their sector so far this year.
The latest trading day saw Oscar Health, Inc. (OSCR) settling at $16.19, representing a +1.19% change from its previous close.
Oscar Health, Inc. (OSCR) closed the most recent trading day at $16.59, moving +1.22% from the previous trading session.